AO4PEEKRG: Hybrid PEEK-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group

Sponsor
Malo Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05589493
Collaborator
Invibio Ltd (Industry)
39
1
1
103.6
0.4

Study Details

Study Description

Brief Summary

The goal of this observational study is to evaluate the outcome of a Poly-ether-ether-ketone

  • acrylic resin prosthesis for full-arch rehabilitation of the atrophic maxillae through the
All-on-4 concept after five years of follow-up. The main question it aims to answer is:
  • What is the survival outcome of the full-arch implant-supported Poly-ether-ether-ketone - acrylic resin prosthesis? The participants already rehabilitated with dental implants will receive a Poly-ether-ehter-ketone prosthesis as a definitive prosthesis.
Condition or Disease Intervention/Treatment Phase
  • Device: Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis
N/A

Detailed Description

Following the learning generated during a development study with implant supported fixed prostheses using polyetheretherketone (PEEK) material, it is necessary to evaluate the outcome of implant supported fixed prosthetic rehabilitations using PEEK material in a routine scenario, following optimized laboratory and treatment protocol.

The study design will be a prospective single cohort to evaluate the long term outcome of fixed prosthetic implant supported rehabilitations. The cohort will be evaluated at 6 months, 12 months and annually thereafter until 5 years of follow-up. At each follow-up assessments multiple evaluaitons will be performed to assess the overall outcome of the restorations.

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective cohort studyProspective cohort study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Hybrid Polyetheretherketone (PEEK)-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group
Actual Study Start Date :
Nov 13, 2017
Actual Primary Completion Date :
Apr 1, 2021
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: All-on-4 PEEK routine

Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis

Device: Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis
A prosthetic full-arch rehabilitation of atrophic maxillae using a PEEk-acrylic resin prosthesis supported by dental implants following the All-on-4 Concept arrangement.
Other Names:
  • PEEK prosthesis
  • Outcome Measures

    Primary Outcome Measures

    1. Survival of the prosthesis [5 years]

      Evaluation of the survival for the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

    Secondary Outcome Measures

    1. Survival of the implants [5 years]

      Evaluation of the survival for implants supporting the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

    2. Incidence of biological complications [5 years]

      Peri-implant infection, abscess, fistulae, suppuration, sinus infection, gingival dehiscence; Nominal (no incidence, incidence)

    3. Incidence of mechanical complications [5 years]

      Loosening or fracture of prosthetic components; Nominal (no incidence, incidence)

    4. Marginal bone resorption [5 years]

      Measured through periapical radiographs, in mm between the implant shoulder and the most apical portion of implant-bone contact; Scale

    5. Denture staining [5 years]

      Veneer discoloration or staining. If JUVORA is exposed same discoloration or staining 0:heavily stained; 10: no stains

    6. In mouth comfort [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    7. Overall chewing feeling [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    8. Oral Health Impact Profile OHIP-14 [5 years]

      Likert Scale (0=least impact/never, 4=highest impact/very often)

    9. Patient tissue reaction [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    10. Framework integrity [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    11. Veneer adhesion [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    12. Manufacture issues [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    13. Handling of material compared to metal [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    14. Aesthetics [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    15. Speech [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    16. Fit [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    17. Hygiene around the implants [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    18. Hygiene - how much plaque/calculus adheres to the prosthesis [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    19. Overall classification from KOL [5 years]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients rehabilitated with immediate function implants for complete edentulous arches through the All-on-4 Concept.

    • Patients in need of definitive implant-supported restorations.

    • Written informed consent from each patient to participate in the study.

    Exclusion Criteria:
    • Hindrance to provide written informed consent. (A patient cannot participate if no written consent is given)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Malo Clinic Lisbon Portugal 1600-042

    Sponsors and Collaborators

    • Malo Clinic
    • Invibio Ltd

    Investigators

    • Principal Investigator: Miguel A de Araújo Nobre, PhD, Director of Research, Development and Education

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Malo Clinic
    ClinicalTrials.gov Identifier:
    NCT05589493
    Other Study ID Numbers:
    • AO4PEEKRoutGroup
    First Posted:
    Oct 21, 2022
    Last Update Posted:
    Oct 21, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Malo Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 21, 2022